Renal biopsy
Dr. Kamal Okasha MD. PhD;
Prof of Int Med & Nephrology, Tanta University,
Egypt.
Member of ESNT, ASN, ISN and ERA-EDTA.
Fellowship of Nephrology, Sask University,
Canada.
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Introduction.
 Indications for renal biopsy.
 Contraindications for renal biopsy.
 Renal biopsy procedure.
 Renal biopsy complications.
 References.
Renal biopsy: Agenda
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 For more than 50 years, renal biopsy has been
an important diagnostic procedure in modern
nephrology.
 Increasing perfection of the biopsy technique has
made the procedure very safe, with rare
complications and few contraindications.
Ther Umsch. 2002 Mar;59(3):110-6.
INTRODUCTION
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Definition: a procedure that is used to obtain
small pieces of kidney tissue to look at under a
microscope.
 It may be done to determine:
 Cause;
 Severity.
 Treatment of a kidney disorder.
 The procedure is generally safe and can provide
valuable information about kidney disease.
INTRODUCTION
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Why?
 A renal biopsy is obtained for a number of reasons:
 Establishment of the exact diagnosis to determine the
nature of recommended therapy.
 Ascertain the degree of active (ie, potentially reversible)
and chronic (ie, irreversible) changes.
 The degree of active or chronic changes helps determine
prognosis and likelihood of response to treatment.
 In addition, kidney biopsy can be performed to help assess
genetic diseases.
INDICATIONS FOR RENAL BIOPSY
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Four groups of patients benefit from the findings
of renal biopsy:
 Nephrotic syndrome,
 Renal disease in a context of systemic disorder,
 Acute renal failure and
 Renal transplant.
 Some patients with non-nephrotic proteinuria,
hematuria and chronic renal failure may also
benefit from the procedure.
INDICATIONS FOR RENAL
BIOPSY
Contraindications
Absolute contraindications
 Patient Refusal
 Bleeding diathesis
 Uncontrolled severe
hypertension
 Uncooperative patient
 Presence of a solitary
native kidney
Relative contraindications
 Azotemia
 certain anatomical
abnormalities of the kidney
 skin infection at the desired
biopsy site
 Hemostasis-altering drugs
(e.g. warfarin or heparin)
 pregnancy
 urinary tract infections
 obesity.
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Preparation:
 Before your biopsy, patients may need testing to see
if they have a blood clotting abnormality or infection.
 To decrease the risk of bleeding, patients should be
asked to stop taking medicines that increase the risk
of bleeding (such as aspirin, aspirin-like compounds,
antiplatlets and anticoagulats) for one to two weeks
before the biopsy.
RENAL BIOPSY PROCEDURE
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Biopsy procedure
 Renal biopsy is usually performed while patients are
awake, after a cleansing agent is applied, and local
anesthesia is given to minimize pain.
 The most common way to perform a biopsy is to use a
needle, which is inserted through the skin and into the
kidney.
 Approach is either by using an ultrasound, x-ray, or
CT scan guidance to localise the right position of the
kidney (usually the lower pole)
Biopsy procedure
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Once the needle is in the right position, a sample
of renal tissue will be taken with the needle.
 In some cases, a different approach is used to
perform the biopsy. An open renal biopsy under
general anesthesia, and a small incision of the
skin and underlying tissue, which is opened to
obtain the kidney specimen.
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 After an open or needle biopsy, patient will be
kept in a recovery or an observation unit for
several hours to monitor for potential
complications, including pain and bleeding.
 Patients may have blood drawn for cbc or repeat
x-rays to monitor for bleeding.
 In some instances, patient will be sent home
after several hours of monitoring. Alternatively,
may be observed in the hospital overnight.
After renal biopsy
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Once it is deemed safe for the patient to go
home, he is not allowed to perform any heavy
lifting or vigorous exercise for one to two weeks.
 Continue to avoid aspirin-like drugs or blood
thinning medications for at least one week or
until your physician has instructed you that it is
safe to take these.
Instructions after renal biopsy:
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 The routine evaluation of a percutaneous renal
biopsy involves examination of the tissue under
LM, IMF, and EM.
 Full clinical data and lab tests must be clearly
mentioned in the pathology request you sent to
the renal pathologist.
After renal biopsy
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Serious complications of renal biopsy are not
common.
 Less serious complications can occur, and
can include bleeding, pain, and development of
an abnormal connection between two blood
vessels (a fistula).
 Rare complications include infection, damage
to blood vessels or other organs, or urine leaks.
RENAL BIOPSY COMPLICATIONS
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Bleeding is the most common complication of
renal biopsy.
 Many people may notice blood in their urine for several days
after a renal biopsy.
 More severe bleeding occurring around the kidney or into
the urine is uncommon but if it occurs you may need a blood
transfusion.
 Very rarely, it may become life threatening and possibly
require a procedure or surgery to stop the bleeding.
 If the urine is bright red or brown for longer than one week
after your biopsy, FUP is needed.
Bleeding
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Pain is a common problem after a renal biopsy.
 Patient may need pain killers to reduce pain post procedure.
 Pain usually resolves within a few hours.
 If severe or prolonged pain, most propably renal
hematoma.
Pain
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 The biopsy needle can accidentally injure the walls
of a nearby artery and vein, and this can lead to
the development of a fistula. Fistulas generally do
not cause problems and usually close on their own
over time.
Arteriovenous fistula
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
 Mendelssohn D, Cole E (October 1995). "Outcomes
of percutaneous kidney biopsy, including those of
solitary native kidneys.". Am J Kidney Dis 26 (4):
580–585.
 Whittier L, Korbet S (November 2004). "Renal
biopsy: update". Current Opinion in Nephrology and
Hypertension 13 (6): 661–665.
 Iversen P, Brun C (September 1951). "Aspiration
biopsy of the kidney". Am. J. Med. 11 (3): 324–30.
References
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
Tanta Nephrology Unit
Renal Biopsy Histopathology Results
2014-2015
Diagnosis No. %
Lupus nephritis 37 26.8
MCD 13 9.4
Glomerulosclerosis 13 9.4
MPGN 12 8.7
FSGS 11 8
ATN 10 7.2
MGN 9 6.5
AIN 7 5
RPGN 6 4.3
TMA 6 4.3
Amyloidosis 5 3.6
CIN 5 3.6
Post-infectious GN 2 1.4
Cast nephropathy 2 1.4
Total 138 100
ESNT-CNE 1st Course Cairo Sept 10-14, 2012
Sales
Lupus nephritis
MCD
Glomerulosclerosis
MPGN
FSGS
ATN
MGN
AIN
RPGN
TMA
Amyloidosis
Tanta Nephrology Unit
Renal Biopsy Histopathology Results
2014-2015
0 10 20 30 40
Lupus nephritis
MCD
Glomerulosclerosis
MPGN
FSGS
ATN
MGN
AIN
RPGN
TMA
Amyloidosis
CIN
Post-infectious GN
Cast nephropathy
ESNT-CNE 1st Course Cairo Sept 10-14, 2012

Renal Biopsy

  • 1.
    Renal biopsy Dr. KamalOkasha MD. PhD; Prof of Int Med & Nephrology, Tanta University, Egypt. Member of ESNT, ASN, ISN and ERA-EDTA. Fellowship of Nephrology, Sask University, Canada.
  • 2.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Introduction.  Indications for renal biopsy.  Contraindications for renal biopsy.  Renal biopsy procedure.  Renal biopsy complications.  References. Renal biopsy: Agenda
  • 3.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  For more than 50 years, renal biopsy has been an important diagnostic procedure in modern nephrology.  Increasing perfection of the biopsy technique has made the procedure very safe, with rare complications and few contraindications. Ther Umsch. 2002 Mar;59(3):110-6. INTRODUCTION
  • 4.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Definition: a procedure that is used to obtain small pieces of kidney tissue to look at under a microscope.  It may be done to determine:  Cause;  Severity.  Treatment of a kidney disorder.  The procedure is generally safe and can provide valuable information about kidney disease. INTRODUCTION
  • 5.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Why?  A renal biopsy is obtained for a number of reasons:  Establishment of the exact diagnosis to determine the nature of recommended therapy.  Ascertain the degree of active (ie, potentially reversible) and chronic (ie, irreversible) changes.  The degree of active or chronic changes helps determine prognosis and likelihood of response to treatment.  In addition, kidney biopsy can be performed to help assess genetic diseases. INDICATIONS FOR RENAL BIOPSY
  • 6.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Four groups of patients benefit from the findings of renal biopsy:  Nephrotic syndrome,  Renal disease in a context of systemic disorder,  Acute renal failure and  Renal transplant.  Some patients with non-nephrotic proteinuria, hematuria and chronic renal failure may also benefit from the procedure. INDICATIONS FOR RENAL BIOPSY
  • 7.
    Contraindications Absolute contraindications  PatientRefusal  Bleeding diathesis  Uncontrolled severe hypertension  Uncooperative patient  Presence of a solitary native kidney Relative contraindications  Azotemia  certain anatomical abnormalities of the kidney  skin infection at the desired biopsy site  Hemostasis-altering drugs (e.g. warfarin or heparin)  pregnancy  urinary tract infections  obesity.
  • 8.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Preparation:  Before your biopsy, patients may need testing to see if they have a blood clotting abnormality or infection.  To decrease the risk of bleeding, patients should be asked to stop taking medicines that increase the risk of bleeding (such as aspirin, aspirin-like compounds, antiplatlets and anticoagulats) for one to two weeks before the biopsy. RENAL BIOPSY PROCEDURE
  • 9.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Biopsy procedure  Renal biopsy is usually performed while patients are awake, after a cleansing agent is applied, and local anesthesia is given to minimize pain.  The most common way to perform a biopsy is to use a needle, which is inserted through the skin and into the kidney.  Approach is either by using an ultrasound, x-ray, or CT scan guidance to localise the right position of the kidney (usually the lower pole) Biopsy procedure
  • 10.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Once the needle is in the right position, a sample of renal tissue will be taken with the needle.  In some cases, a different approach is used to perform the biopsy. An open renal biopsy under general anesthesia, and a small incision of the skin and underlying tissue, which is opened to obtain the kidney specimen.
  • 11.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  After an open or needle biopsy, patient will be kept in a recovery or an observation unit for several hours to monitor for potential complications, including pain and bleeding.  Patients may have blood drawn for cbc or repeat x-rays to monitor for bleeding.  In some instances, patient will be sent home after several hours of monitoring. Alternatively, may be observed in the hospital overnight. After renal biopsy
  • 12.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Once it is deemed safe for the patient to go home, he is not allowed to perform any heavy lifting or vigorous exercise for one to two weeks.  Continue to avoid aspirin-like drugs or blood thinning medications for at least one week or until your physician has instructed you that it is safe to take these. Instructions after renal biopsy:
  • 13.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  The routine evaluation of a percutaneous renal biopsy involves examination of the tissue under LM, IMF, and EM.  Full clinical data and lab tests must be clearly mentioned in the pathology request you sent to the renal pathologist. After renal biopsy
  • 14.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Serious complications of renal biopsy are not common.  Less serious complications can occur, and can include bleeding, pain, and development of an abnormal connection between two blood vessels (a fistula).  Rare complications include infection, damage to blood vessels or other organs, or urine leaks. RENAL BIOPSY COMPLICATIONS
  • 15.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Bleeding is the most common complication of renal biopsy.  Many people may notice blood in their urine for several days after a renal biopsy.  More severe bleeding occurring around the kidney or into the urine is uncommon but if it occurs you may need a blood transfusion.  Very rarely, it may become life threatening and possibly require a procedure or surgery to stop the bleeding.  If the urine is bright red or brown for longer than one week after your biopsy, FUP is needed. Bleeding
  • 16.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Pain is a common problem after a renal biopsy.  Patient may need pain killers to reduce pain post procedure.  Pain usually resolves within a few hours.  If severe or prolonged pain, most propably renal hematoma. Pain
  • 17.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  The biopsy needle can accidentally injure the walls of a nearby artery and vein, and this can lead to the development of a fistula. Fistulas generally do not cause problems and usually close on their own over time. Arteriovenous fistula
  • 18.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012  Mendelssohn D, Cole E (October 1995). "Outcomes of percutaneous kidney biopsy, including those of solitary native kidneys.". Am J Kidney Dis 26 (4): 580–585.  Whittier L, Korbet S (November 2004). "Renal biopsy: update". Current Opinion in Nephrology and Hypertension 13 (6): 661–665.  Iversen P, Brun C (September 1951). "Aspiration biopsy of the kidney". Am. J. Med. 11 (3): 324–30. References
  • 19.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012 Tanta Nephrology Unit Renal Biopsy Histopathology Results 2014-2015 Diagnosis No. % Lupus nephritis 37 26.8 MCD 13 9.4 Glomerulosclerosis 13 9.4 MPGN 12 8.7 FSGS 11 8 ATN 10 7.2 MGN 9 6.5 AIN 7 5 RPGN 6 4.3 TMA 6 4.3 Amyloidosis 5 3.6 CIN 5 3.6 Post-infectious GN 2 1.4 Cast nephropathy 2 1.4 Total 138 100
  • 20.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012 Sales Lupus nephritis MCD Glomerulosclerosis MPGN FSGS ATN MGN AIN RPGN TMA Amyloidosis Tanta Nephrology Unit Renal Biopsy Histopathology Results 2014-2015 0 10 20 30 40 Lupus nephritis MCD Glomerulosclerosis MPGN FSGS ATN MGN AIN RPGN TMA Amyloidosis CIN Post-infectious GN Cast nephropathy
  • 21.
    ESNT-CNE 1st CourseCairo Sept 10-14, 2012